Medical News / AAAAI 2021 Research Suggests No Raised Risk of COVID-19 Severity with Asthma

A collection of articles published at the American Academy of Allergy, Asthma & Immunology (AAAAI) 2021 Virtual Sessions this week would indicate that patients with asthma may not actually faced heightened risk of COVID-19 severity, hospitalization, or even death. In fact, the broad interpretation of asthma as a chronic respiratory disease may not be suitable in interpreting an individual’s risk with COVID-19 infection. Source: MDMag. To view the third party content, kindly click on the link below or read more. You will then leave this site and enter a third party site.

read more

MORE MEDICAL NEWS
Omalizumab (Xolair) benefitted sleep disturbance among patients with nasal polyposis over a span of 76 weeks, ... read more
As covered by Lakiea Wright, MD, in a previous interview segment with HCPLive® during the American ... read more
At the American Academy of Allergy, Asthma & Immunology (AAAAI) 2021 Virtual Sessions this weekend, a ... read more
New research shows a recently revised diagnostic criteria is sufficient for emergency departments to identify and ... read more